BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10441970)

  • 1. Serum copper and zinc content in non-small cell lung cancer: abnormalities and clinical correlates.
    Ferrigno D; Buccheri G; Camilla T
    Monaldi Arch Chest Dis; 1999 Jun; 54(3):204-8. PubMed ID: 10441970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract].
    Sanada S; Ogura K; Kiriyama T; Yoshida O
    Hinyokika Kiyo; 1985 Aug; 31(8):1299-316. PubMed ID: 4083194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum copper and zinc levels in patients with cervical cancer.
    Chen CA; Hwang JL; Kuo TL; Hsieh CY; Huang SC
    J Formos Med Assoc; 1990 Aug; 89(8):677-82. PubMed ID: 1981230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum levels of copper and zinc in patients with lung cancer].
    Altavilla G; Adamo V; Alafaci E; Buemi B; Chillemi S; La Scala R; Marabello G; Palmara D
    Minerva Med; 1985 Nov; 76(44):2117-20. PubMed ID: 4069424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma].
    Wu HY
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):335-8. PubMed ID: 3248498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-case study comparing the usefulness of serum trace elements (Cu, Zn and Se) and tumor markers (CEA, SCC and SLX) in non-small cell lung cancer patients.
    Oyama T; Kawamoto T; Matsuno K; Osaki T; Matsumoto A; Isse T; Nakata S; Ozaki S; Sugaya M; Yasuda M; Yamashita T; Takenoyama M; Sugio K; Yasumoto K
    Anticancer Res; 2003; 23(1B):605-12. PubMed ID: 12680155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper and zinc levels in serum from human patients with sarcomas.
    Fisher GL; Byers VS; Shifrine M; Levin AS
    Cancer; 1976 Jan; 37(1):356-63. PubMed ID: 764964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum copper and zinc levels in patients with nasopharyngeal carcinoma.
    Lian SL; Hsu HY; Lin SM
    Taiwan Yi Xue Hui Za Zhi; 1989 Mar; 88(3):236-9. PubMed ID: 2794920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The determination of Cu and Zn levels in the serum and gastric juice of patients with gastric cancer].
    Wang CS
    Zhonghua Wai Ke Za Zhi; 1989 Jul; 27(7):401-3, 444. PubMed ID: 2598740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum zinc, serum copper, and the Cu/Zn ratio in patients with epidermoid cancers of the head and neck.
    Garofalo JA; Erlandson E; Strong EW; Lesser M; Gerold F; Spiro R; Schwartz M; Good RA
    J Surg Oncol; 1980; 15(4):381-6. PubMed ID: 7453188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of serum copper and zinc levels in patients with nasopharyngeal carcinoma by radiotherapy.
    Hsu HY; Lin SY; Huang CJ; Lian SL; Ho YH
    Biol Trace Elem Res; 1994; 46(1-2):1-13. PubMed ID: 7888274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum copper and zinc measurement in patients with osteogenic sarcoma.
    Breiter DN; Diasio RB; Neifeld JP; Roush ML; Rosenberg SA
    Cancer; 1978 Aug; 42(2):598-602. PubMed ID: 307981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the copper/zinc ratio in the diagnosis of lung cancer.
    Dìez M; Cerdàn FJ; Arroyo M; Balibrea JL
    Cancer; 1989 Feb; 63(4):726-30. PubMed ID: 2914279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency of serum copper/zinc ratio for differential diagnosis of patients with and without lung cancer.
    Oyama T; Matsuno K; Kawamoto T; Mitsudomi T; Shirakusa T; Kodama Y
    Biol Trace Elem Res; 1994 Aug; 42(2):115-27. PubMed ID: 7981002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
    Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Probe into internal relation between classification of the differentiation-syndrome in traditional Chinese medicine and serum copper and zinc in lung cancer].
    Mi YY; Zhou MZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Mar; 12(3):154-6, 133. PubMed ID: 1324041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and Whole Blood Cu and Zn Status in Predicting Mortality in Lung Cancer Patients.
    Zabłocka-Słowińska K; Prescha A; Płaczkowska S; Porębska I; Kosacka M; Pawełczyk K
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33375477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship of serum trace elements to lung cancer and its clinical application].
    Zhao X; Han C; Jing J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Oct; 19(5):286-9. PubMed ID: 10322688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of serum copper and zinc concentrations in cancer patients.
    Zowczak M; Iskra M; Torliński L; Cofta S
    Biol Trace Elem Res; 2001; 82(1-3):1-8. PubMed ID: 11697759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum zinc, copper, and the Cu/Zn ratio in patients with benign and malignant breast lesions.
    Garofalo JA; Ashikari H; Lesser ML; Menendez-Botet C; Cunningham-Rundles S; Schwartz MK; Good RA
    Cancer; 1980 Dec; 46(12):2682-5. PubMed ID: 7448705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.